Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer kills more than 10,000 men in England each year and testing has never been more important or more debated. For the ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
I know prostate cancer is common, but I’m not sure who is most at risk or whether there are symptoms to watch for. When ...
A prostate cancer charity has voiced concerns regarding the planned introduction of at-home prostate-specific antigen (PSA) tests, urging for greater clarity on how men with the disease will utilise ...
Today, men with average risk can schedule a less invasive Prostate-Specific Antigen screening test.
Answer: The most common diagnostic tool for prostate cancer is a blood test for a prostate-specific antigen (PSA). PSA is a ...
New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
A new test could make it easier to detect high-risk prostate cancer cases earlier. The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results